Clinical Trial Update: Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completed Phase 1/Phase 2 clinical trial evaluating Rexin-G for pancreatic cancer, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Rexin-G

Snippet

Sponsor: Epeius Biotechnologies | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED